EnzyQuest, receives a VC fund (400K €) from Uni.Fund, an EquiFund partner (EquiFund is an initiative created by the Hellenic Republic in cooperation with the European Investment Fund)​.

According to Uni.Fund, EnzyQuest is the first company that is active in the field of enzyme biotechnology in Southeast Europe. Having already 70 products in its portfolio, as well as a number of new ones under development, EnzyQuest enters dynamically on the world map, with a strong and innovative element of the identification and discovery of enzymes with new properties and pioneering applications by Extremophilic organisms, i.e. microorganisms that have developed enzymes that operate in extreme conditions (saltness, temperature, etc.).